Peptron, Inc.

KOSDAQ:A087010 Stock Report

Market Cap: ₩2.2t

Peptron Past Earnings Performance

Past criteria checks 0/6

Peptron's earnings have been declining at an average annual rate of -0.3%, while the Life Sciences industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 3.5% per year.

Key information

-0.3%

Earnings growth rate

7.8%

EPS growth rate

Life Sciences Industry Growth53.7%
Revenue growth rate3.5%
Return on equity-97.8%
Net Margin-841.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Peptron (KOSDAQ:087010) Is Carrying A Fair Bit Of Debt

Jun 10
Peptron (KOSDAQ:087010) Is Carrying A Fair Bit Of Debt

Does Peptron (KOSDAQ:087010) Have A Healthy Balance Sheet?

Feb 26
Does Peptron (KOSDAQ:087010) Have A Healthy Balance Sheet?

Peptron's (KOSDAQ:087010) Stock Price Has Reduced 53% In The Past Five Years

Dec 25
Peptron's (KOSDAQ:087010) Stock Price Has Reduced 53% In The Past Five Years

Revenue & Expenses Breakdown

How Peptron makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A087010 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,407-20,2504,87011,377
30 Jun 242,502-19,6224,64811,209
31 Mar 242,656-15,9414,94311,337
31 Dec 233,342-15,9225,21311,444
30 Sep 233,335-18,9775,20313,602
30 Jun 233,880-17,8815,36013,186
31 Mar 234,194-17,0455,11613,197
31 Dec 225,814-15,0634,86113,367
30 Sep 225,811-12,7354,84012,389
30 Jun 225,414-13,9714,87812,813
31 Mar 228,598-11,8845,02113,563
31 Dec 216,625-15,0425,00414,842
30 Sep 216,656-15,9294,92915,777
30 Jun 216,748-15,9624,73716,105
31 Mar 213,439-19,9084,54215,619
31 Dec 203,121-18,3824,19114,180
30 Sep 202,744-23,4563,76312,580
30 Jun 202,215-22,8213,55612,058
31 Mar 201,683-19,2223,30310,992
31 Dec 191,801-17,7183,2419,835
30 Sep 192,319-8,4223,4258,747
30 Jun 192,806-7,2353,2887,651
31 Mar 193,255-4,3143,2186,568
31 Dec 183,862-3,7263,0746,069
30 Sep 184,383-4,2012,7505,800
30 Jun 184,142-2,5752,3994,765
31 Mar 183,915-4,7602,1434,205
31 Dec 173,215-4,4272,0643,737
30 Sep 172,587-4,1642,0763,373
30 Jun 172,761-4,0432,0053,143
31 Mar 172,951-3,6071,9123,030
31 Dec 163,131-3,1911,8752,771
30 Sep 162,930-3,0801,6692,374
30 Jun 163,028-3,0651,7932,343
31 Mar 162,691-3,0571,7072,110
31 Dec 152,812-2,7341,6062,006
30 Sep 152,571-2,6171,6861,842
30 Jun 152,565-2,6211,5002,037
31 Mar 152,874-2,6361,5702,026
31 Dec 142,484-3,0461,6081,991

Quality Earnings: A087010 is currently unprofitable.

Growing Profit Margin: A087010 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A087010 is unprofitable, and losses have increased over the past 5 years at a rate of 0.3% per year.

Accelerating Growth: Unable to compare A087010's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A087010 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (39.6%).

Return on Equity

High ROE: A087010 has a negative Return on Equity (-97.77%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 02:57
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Peptron, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Si Hyoung ParkIBK Securities Co. Ltd.
Wan KuNH Investment & Securities Co., Ltd.
Dong Gun LeeShinhan Investment Corp.